{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:24:11Z","timestamp":1782962651454,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00405-016-3927-3","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T10:11:33Z","timestamp":1455271893000},"page":"3083-3090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of acyclovir and famciclovir for the treatment of Bell\u2019s palsy"],"prefix":"10.1007","volume":"273","author":[{"given":"Ho Joong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Suh","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Geun","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"3927_CR1","first-page":"107","volume":"2","author":"E Peitersen","year":"1982","unstructured":"Peitersen E (1982) The natural history of Bell\u2019s palsy. Am J Otol 2:107\u2013111","journal-title":"Am J Otol"},{"key":"3927_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/00016489209137502","volume":"112","author":"T Takasu","year":"1992","unstructured":"Takasu T, Furuta Y, Sato KC, Fukuda S, Inuyama Y, Nagashima K (1992) Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol 112:4\u201311","journal-title":"Acta Otolaryngol"},{"key":"3927_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00005","volume":"124","author":"S Murakami","year":"1996","unstructured":"Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N (1996) Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124:27\u201330","journal-title":"Ann Intern Med"},{"key":"3927_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s100720200035","volume":"23","author":"G Lagalla","year":"2002","unstructured":"Lagalla G, Logullo F, Di Bella P, Provinciali L, Ceravolo MG (2002) Influence of early high-dose steroid treatment on Bell\u2019s palsy evolution. Neurol Sci 23:107\u2013112","journal-title":"Neurol Sci"},{"key":"3927_CR5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0385-8146(00)00105-X","volume":"28","author":"Y Furuta","year":"2001","unstructured":"Furuta Y, Ohtani F, Chida E, Mesuda Y, Fukuda S, Inuyama Y (2001) Herpes simplex virus type 1 reactivation and antiviral therapy in patients with acute peripheral facial palsy. Auris Nasus Larynx 28:S13\u2013S76","journal-title":"Auris Nasus Larynx"},{"key":"3927_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<162::AID-JMV3>3.0.CO;2-3","volume":"54","author":"Y Furuta","year":"1998","unstructured":"Furuta Y, Fukuda S, Chida E et al (1998) Reactivation of herpes simplex virus type I in patients with Bell\u2019s palsy. J Med Virol 54:162\u2013164","journal-title":"J Med Virol"},{"key":"3927_CR7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1212\/WNL.56.7.830","volume":"56","author":"PM Grogan","year":"2001","unstructured":"Grogan PM, Gronseth GS (2001) Practice parameter: steroids, acyclovir, and surgery for Bell`s palsy (an evidence-based review) V report of the quality standards subcommittee of the American academy of neurology. Neurology 56:830\u2013836","journal-title":"Neurology"},{"key":"3927_CR8","first-page":"11","volume":"9","author":"I Gagyor","year":"2015","unstructured":"Gagyor I, Madhok VB, Daly F et al (2015) Antiviral treatment for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 9:11","journal-title":"Cochrane Database Syst Rev"},{"key":"3927_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/09563202930040S602","volume":"4","author":"M Pue","year":"1993","unstructured":"Pue M, Benet LZ (1993) Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 4:47\u201355","journal-title":"Antiviral Chem Chemother"},{"key":"3927_CR10","first-page":"96","volume":"23","author":"R Standring-Cox","year":"1994","unstructured":"Standring-Cox R, Bacon TH, Howard B, Gilbart J, Boyd MR (1994) Prolonged activity of penciclovir in cell culture against varicella-zoster virus. Antivir Res 23:96","journal-title":"Antivir Res"},{"key":"3927_CR11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/019459988509300202","volume":"93","author":"JW House","year":"1985","unstructured":"House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146\u2013147","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3927_CR12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.12288","volume":"277","author":"HM Kang","year":"2015","unstructured":"Kang HM, Jung SY, Byun JY, Park MS, Yeo SG (2015) Steroid plus antiviral treatment for Bell\u2019s palsy. J Intern Med 277:532\u2013539","journal-title":"J Intern Med"},{"key":"3927_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.mao.0000265190.29969.12","volume":"28","author":"N Hato","year":"2007","unstructured":"Hato N, Yamada H, Kohno H et al (2007) Valacyclovir and prednisolone treatment for Bell\u2019s palsy (idiopathic facial paralysis). Otol Neurotol 28:408\u2013413","journal-title":"Otol Neurotol"},{"key":"3927_CR14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa072006","volume":"8","author":"FM Sullivan","year":"2007","unstructured":"Sullivan FM, Swan IR, Donnan PT et al (2007) Early treatment with prednisolone or acyclovir in Bell\u2019s palsy. N Engl J Med 8:1598\u20131607","journal-title":"N Engl J Med"},{"key":"3927_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjoto.2007.05.001","volume":"29","author":"SG Yeo","year":"2008","unstructured":"Yeo SG, Lee YC, Park DC, Cha CI (2008) Acyclovir plus steroid vs steroid alone in the treatment of Bell\u2019s palsy. Am J Otolaryngol 29:163\u2013166","journal-title":"Am J Otolaryngol"},{"key":"3927_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00005537-199804000-00020","volume":"108","author":"JI Diego De","year":"1998","unstructured":"De Diego JI, Prim MP, De Sarria MJ, Madero R, Gavilan J (1998) Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 108:573\u2013575","journal-title":"Laryngoscope"},{"key":"3927_CR17","first-page":"19","volume":"39","author":"S Inanli","year":"2000","unstructured":"Inanli S, Tutkun A, Ozturk O et al (2000) Idiopathic facial nerve paralysis treatment with aciclovir and prednisolone alone. Turk Arch Otol 39:19\u201324","journal-title":"Turk Arch Otol"},{"key":"3927_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/000348949610500508","volume":"105","author":"KK Adour","year":"1996","unstructured":"Adour KK, Ruboyianes JM, Von Doersten PG et al (1996) Bell\u2019s palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 105:371\u2013378","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"3927_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/12.suppl_B.29","volume":"12","author":"P Miranda De","year":"1983","unstructured":"De Miranda P, Blum MR (1983) Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 12:29\u201337","journal-title":"J Antimicrob Chemother"},{"key":"3927_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.01.050","volume":"317","author":"GE Granero","year":"2006","unstructured":"Granero GE, Amidon GL (2006) Stability of valacyclovir: implications for its oral bioavailability. Int J Pharm 317:14\u201318","journal-title":"Int J Pharm"},{"key":"3927_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/09563202930040S602","volume":"4","author":"M Pue","year":"1993","unstructured":"Pue M, Benet LZ (1993) Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 4:47\u201355","journal-title":"Antiviral Chem Chemother"},{"key":"3927_CR22","first-page":"96","volume":"23","author":"R Standring-Cox","year":"1994","unstructured":"Standring-Cox R, Bacon TH, Howard B, Gilbart J, Boyd MR (1994) Prolonged activity of penciclovir in cell culture against varicella-zoster virus. Antivir Res 23:96","journal-title":"Antivir Res"},{"key":"3927_CR23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jmv.23917","volume":"86","author":"O Turriziani","year":"2014","unstructured":"Turriziani O, Falasca F, Maida P et al (2014) Early collection of saliva specimens from Bell\u2019s palsy patients: quantitative analysis of HHV-6, HSV-1, and VZV. J Med Virol 86:1752\u20131758","journal-title":"J Med Virol"},{"key":"3927_CR24","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00415-008-0008-6","volume":"255","author":"M Minnerop","year":"2008","unstructured":"Minnerop M, Herbst M, Fimmers R et al (2008) Bell\u2019s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 255:1726\u20131730","journal-title":"J Neurol"},{"key":"3927_CR25","first-page":"605","volume":"20","author":"M Shahidullah","year":"2011","unstructured":"Shahidullah M, Haque A, Islam MR et al (2011) Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell\u2019s palsy. Mymensingh Med J 20:605\u2013613","journal-title":"Mymensingh Med J"},{"key":"3927_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mlg.0000248737.65607.9e","volume":"117","author":"K Kawaguchi","year":"2007","unstructured":"Kawaguchi K, Inamura H, Abe Y et al (2007) Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell\u2019s palsy. Laryngoscope 117:147\u2013156","journal-title":"Laryngoscope"},{"key":"3927_CR27","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00415-008-0008-6","volume":"255","author":"R Fimmers","year":"2008","unstructured":"Fimmers R, Matz B (2008) Bell\u2019s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 255:1726\u20131730","journal-title":"J Neurol"},{"key":"3927_CR28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1474-4422(08)70221-7","volume":"7","author":"M Engstr\u00f6m","year":"2008","unstructured":"Engstr\u00f6m M, Berg T, Stjernquist-Desatnik A et al (2008) Prednisolone and valaciclovir in Bell\u2019s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 7:993\u20131000","journal-title":"Lancet Neurol"},{"key":"3927_CR29","first-page":"68","volume":"19","author":"ML Antunes","year":"2000","unstructured":"Antunes ML, Fukuda Y, Testa JRG (2000) Clinical treatment of Bell\u2019s palsy: comparative study among valaciclovir plus deflazacort, deflazacort and placebo. Acta AWHO 19:68\u201375","journal-title":"Acta AWHO"},{"key":"3927_CR30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/000164802320401694","volume":"549","author":"E Peitersen","year":"2002","unstructured":"Peitersen E (2002) Bell\u2019s palsy: the spontaneous course of 2500 peripheral facial nerve palsies of different etiologics. Acta Otolaryngol Suppl 549:4\u201330","journal-title":"Acta Otolaryngol Suppl"},{"key":"3927_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s004050050203","volume":"256","author":"V Danielidis","year":"1999","unstructured":"Danielidis V, Skevas A, Van Cauwenberge P et al (1999) A comparative study of age and degree of facial nerve recovery in patients with Bell\u2019s palsy. Eur Arch Otorhinoraphy 256:520\u2013522","journal-title":"Eur Arch Otorhinoraphy"},{"key":"3927_CR32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/MAO.0b013e31821da2c6","volume":"32","author":"K Mantsopoulos","year":"2011","unstructured":"Mantsopoulos K, Psillas G, Psychogios G et al (2011) Predicting the longterm outcome after idiopathic facial nerve paralysis. Otol Neurotol 32:848\u2013851","journal-title":"Otol Neurotol"},{"key":"3927_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anl.2006.09.005","volume":"34","author":"SW Yeo","year":"2007","unstructured":"Yeo SW, Lee DH, Jun BC et al (2007) Analysis of prognostic factors in Bell\u2019s palsy and Ramsay Hunt syndrome. Auris Nasus Larynx 34:159\u2013164","journal-title":"Auris Nasus Larynx"},{"key":"3927_CR34","first-page":"1106","volume-title":"Otolaryngology","author":"M May","year":"1991","unstructured":"May M, Shambaugh GE (1991) Facial nerve paralysis. In: Paparella MM, Shumrick DA, Gluckman JL, Meyerhoff WL (eds) Otolaryngology, 3rd edn. W.B. Saunders, Philadelphia, p 1106","edition":"3"},{"key":"3927_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MLG.0b013e31815d8e68","volume":"118","author":"M Grosheva","year":"2008","unstructured":"Grosheva M, Wittekindt C, Guntinas-Lichius O (2008) Prognostic value of electroneurography and electromyography in facial palsy. Laryngoscope 118:394\u2013397","journal-title":"Laryngoscope"},{"key":"3927_CR36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MAO.0b013e3182829636","volume":"34","author":"HY Lee","year":"2013","unstructured":"Lee HY, Byun JY, Park MS, Yeo SG (2013) Effect of aging on the prognosis of Bell\u2019s palsy. Otol Neurotol 34:766\u2013770","journal-title":"Otol Neurotol"},{"key":"3927_CR37","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00405-013-2676-9","volume":"271","author":"T Fujiwara","year":"2014","unstructured":"Fujiwara T, Hato N, Gyo K, Yanagihara N (2014) Prognostic factors of Bell\u2019s palsy: prospective patient collected observational study. Eur Arch Otorhinolaryngol 271:1891\u20131895","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3927_CR38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/MAO.0b013e31822558de","volume":"32","author":"N Takemoto","year":"2011","unstructured":"Takemoto N, Horii A, Sakata Y, Inohara H (2011) Prognostic factors of peripheral facialpalsy: multivariate analysis followed by receiver operating characteristic and Kaplan\u2013Meier analyses. Otol Neurotol 32:1031\u20131036","journal-title":"Otol Neurotol"},{"key":"3927_CR39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/00016480601075399","volume":"127","author":"A Kanazawa","year":"2007","unstructured":"Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M, Takenaka H (2007) Prognosis for Bell\u2019s palsy: a comparison of diabetic and nondiabetic patients. Acta Otolaryngol 127:888\u2013891","journal-title":"Acta Otolaryngol"},{"key":"3927_CR40","first-page":"283","volume":"26","author":"A Martinez","year":"1986","unstructured":"Martinez A (1986) Diabetic neuropathy. Topography, general electrophysiologic features, effect of ischemia on nerve evoked potential and frequency of the entrapment neuropathy. Electromyogr Clin Neurophysiol 26:283\u2013295","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"3927_CR41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00415-005-0672-8","volume":"252","author":"E Stamboulis","year":"2005","unstructured":"Stamboulis E, Vassilopoulos D, Kalfakis N (2005) Symptomatic focal mononeuropathies in diabetic patients: increased or not? J Neurol 252:448\u2013452","journal-title":"J Neurol"},{"key":"3927_CR42","first-page":"1219","volume-title":"Diabetic neuropathy","author":"PK Thomas","year":"1993","unstructured":"Thomas PK, Tomlinson D (1993) Diabetic and hypoglycemic neuropathy. In: Dyck P, Thomas PK, Asbury A et al (eds) Diabetic neuropathy, 3rd edn. Saunders WB, Philadelphia, pp 1219\u20131250","edition":"3"},{"key":"3927_CR43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3122\/jabfm.2012.06.120084","volume":"25","author":"M Riga","year":"2012","unstructured":"Riga M, Kefalidis G, Danielides V (2012) The role of diabetes mellitus in the clinical presentation and prognosis of Bell palsy. J Am Board Fam Med 25:819\u2013826","journal-title":"J Am Board Fam Med"},{"key":"3927_CR44","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1288\/00005537-199012000-00003","volume":"100","author":"MK Schwaber","year":"1990","unstructured":"Schwaber MK, Larson TC III, Zealear DL, Creasy J (1990) Gadolinium-enhanced magnetic resonance imagingin Bell\u2019s palsy. Laryngoscope 100:1264\u20131269","journal-title":"Laryngoscope"},{"key":"3927_CR45","first-page":"CD001869","volume":"3","author":"D Allen","year":"2004","unstructured":"Allen D, Dunn L (2004) Aciclovir or valaciclovir for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 3:CD001869","journal-title":"Cochrane Database Syst Rev"}],"updated-by":[{"DOI":"10.1007\/s00405-016-4216-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000}}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-016-3927-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3927-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T10:07:21Z","timestamp":1567591641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-016-3927-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3927"],"URL":"https:\/\/doi.org\/10.1007\/s00405-016-3927-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00405-016-4216-x","asserted-by":"object"}]},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}